We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+7.76%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$4.75B
AUM Growth
+$529M
Cap. Flow
+$146M
Cap. Flow %
3.08%
Top 10 Hldgs %
47.97%
Holding
745
New
128
Increased
150
Reduced
259
Closed
162
Avg Time Held Equity + Options
3.8 quarters
Top 10 Avg Time Held Equity + Options
1.1 quarters
Top 20 Avg Time Held Equity + Options
1.1 quarters
Avg Time Held Equity only
3.9 quarters
Top 10 Avg Time Held Equity only
1.1 quarters
Top 20 Avg Time Held Equity only
1.1 quarters

Top Buys

Rank Stock Value
1
SGEN
Seagen Inc. Common Stock
SGEN
+$253M
2
PDCE
PDC Energy, Inc.
PDCE
+$210M
3
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$206M
4
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
+$135M
5
LSI
Life Storage, Inc.
LSI
+$87.5M

Top Sells

Rank Stock Value
1
FHN icon
First Horizon
FHN
+$179M
2
AQUA
Evoqua Water Technologies Corp. Common Stock
AQUA
+$146M
3
PRVB
Provention Bio, Inc. Common Stock
PRVB
+$70.5M
4
TSEM icon
Tower Semiconductor
TSEM
+$50.8M
5
XM
Qualtrics International Inc. Class A Common Stock
XM
+$45.3M

Sector Composition

Rank Sector Weight
1 Healthcare 32.35%
2 Technology 15.68%
3 Financials 11.99%
4 Miscellaneous 10.5%
5 Real Estate 8.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
PDM icon
251
Piedmont Realty Trust
PDM
$1.13B
$2.3M 0.05%
+316,540
New +$2.11M
2023 Q2
0 quarters
FCX icon
252
Freeport-McMoran
FCX
$106B
$2.3M 0.05%
+57,393
New +$2.19M
2023 Q2
0 quarters
AGEN icon
253
Agenus
AGEN
$346M
$2.26M 0.05%
70,704
+6,334
+10% +$203K
2022 Q1
5 quarters
BDN icon
254
Brandywine Realty Trust
BDN
$461M
$2.26M 0.05%
+486,115
New +$1.98M
2023 Q2
0 quarters
BSX icon
255
Boston Scientific
BSX
$61.9B
$2.24M 0.05%
41,392
-4,616
-10% -$241K
2022 Q1
5 quarters
ROKU icon
256
Roku
ROKU
$22.7B
$2.24M 0.05%
35,000
-35,000
-50% -$2.13M
2023 Q1
1 quarter
KROS icon
257
Keros Therapeutics
KROS
$237M
$2.22M 0.05%
55,341
+9,857
+22% +$432K
2022 Q1
5 quarters
AVTR icon
258
Avantor
AVTR
$10.6B
$2.21M 0.05%
107,470
-6,863
-6% -$139K
2022 Q1
5 quarters
FNVT icon
259
DELISTED
Finnovate Acquisition Corp. Class A Ordinary Shares
FNVT
$2.2M 0.05%
207,992
-4,689
-2% -$49.3K
2021 Q4
6 quarters
BOX icon
260
Box
BOX
$4.99B
$2.2M 0.05%
+75,000
New +$2.08M
2023 Q2
0 quarters
DNAD
261
DELISTED
Social Capital Suvretta Holdings Corp. IV Class A Ordinary Shares
DNAD
$2.19M 0.05%
211,253
-4,761
-2% -$49K
2021 Q2
8 quarters
CITE icon
262
DELISTED
Cartica Acquisition Corp Class A Ordinary Shares
CITE
$2.18M 0.05%
203,921
-4,597
-2% -$48.8K
2022 Q2
4 quarters
MRTX
263
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$2.16M 0.05%
59,698
+12,448
+26% +$513K
2022 Q4
2 quarters
MWA icon
264
Mueller Water Products
MWA
$3.38B
$2.13M 0.05%
+131,500
New +$1.87M
2023 Q2
0 quarters
HLN icon
265
Haleon
HLN
$41B
$2.13M 0.04%
254,185
+12,523
+5% +$107K
2022 Q3
3 quarters
RCUS icon
266
Arcus Biosciences
RCUS
$3.11B
$2.12M 0.04%
104,412
-10,068
-9% -$192K
2022 Q2
4 quarters
SPEC icon
267
DELISTED
Spectaire Holdings, Inc. Common Stock
SPEC
$2.11M 0.04%
192,601
-6,292
-3% -$68.5K
2022 Q1
5 quarters
VERA icon
268
Vera Therapeutics
VERA
$2.15B
$2.05M 0.04%
127,991
-95,477
-43% -$862K
2023 Q1
1 quarter
IOVA icon
269
Iovance Biotherapeutics
IOVA
$6.62B
$2.04M 0.04%
289,384
-18,828
-6% -$135K
2022 Q1
5 quarters
XME icon
270
State Street SPDR S&P Metals & Mining ETF
XME
$4.22B
$2.03M 0.04%
+40,000
New +$1.96M
2023 Q2
0 quarters
TCOM icon
271
Trip.com Group
TCOM
$24.5B
$2.01M 0.04%
+57,500
New +$2M
2023 Q2
0 quarters
PHAT icon
272
Phathom Pharmaceuticals
PHAT
$587M
$2.01M 0.04%
140,280
+40,187
+40% +$463K
2022 Q1
5 quarters
ATRC icon
273
AtriCure
ATRC
$2.84B
$1.99M 0.04%
40,293
-867
-2% -$40K
2022 Q3
3 quarters
BCYC icon
274
Bicycle Therapeutics
BCYC
$272M
$1.99M 0.04%
77,902
-2,817
-3% -$65.4K
2022 Q1
5 quarters
IMUX icon
275
Immunic
IMUX
$112M
$1.99M 0.04%
79,169
+10,556
+15% +$177K
2022 Q1
5 quarters
9 10
11
12 13

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

UBS O'Connor's Q2 2023 Portfolio in Review

As of Q2 2023, UBS O'Connor held 745 positions worth $4.75B, up 13% from $4.22B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

UBS O'Connor deployed $146M of net new capital in Q2 2023, opening 128 new positions and adding to 150 existing holdings. Its largest new stake was PDC Energy, Inc.: 3,101,445 shares worth $221M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 21% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Tower Semiconductor, an estimated $50.8M trimmed.

  • UBS O'Connor's largest Q2 2023 buy was PDC Energy, Inc.: 3,101,445 shares worth $221M.
  • UBS O'Connor added most to Seagen Inc. Common Stock in Q2 2023, an estimated $253M increase.
  • UBS O'Connor's biggest Q2 2023 reduction was Tower Semiconductor, cutting an estimated $50.8M.
  • UBS O'Connor fully exited First Horizon in Q2 2023, selling an estimated $179M.
  • UBS O'Connor's ten largest holdings make up 48% of its $4.75B portfolio in Q2 2023.
  • UBS O'Connor opened 128 new positions and closed 162 in Q2 2023.
  • UBS O'Connor's portfolio value rose 13% quarter-over-quarter to $4.75B.

Based on UBS O'Connor's 13F filing for Q2 2023, filed 14 Aug 2023.